NIH #1R35GM160071-01
Viral Biosensors of Host Post-Translational Modifications
- Amount
- $421K
- Period
- 2025-08-01 → 2030-07-31
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES
SARS-CoV-2 and COVID-19 Research · Infectious Diseases
5 total · 1 active
NIH #1R35GM160071-01
Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES
NIH #1K99AI163868-01A1
Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
NIH #5F32CA239333-03
Awarded at UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Zenodo (CERN European Organization for Nuclear Research) · 2026-06-23
Open MIND · 2026-06-23
Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor
Molecular Aspects of Medicine · 2025-11-10
medRxiv · 2025-10-14 · 2 citations
bioRxiv (Cold Spring Harbor Laboratory) · 2025-07-28 · 1 citations
Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer PathwaysPreprint
iScience · 2025-06-07 · 2 citations
Malaria exposure remodels the plasma proteome of Ghanaian children
BMC Infectious Diseases · 2025-02-03 · 2 citations
SARS-CoV-2 evolution balances conflicting roles of N protein phosphorylation
PLoS Pathogens · 2024-11-21 · 22 citations
STAR Protocols · 2024-11-01 · 2 citations
Fibrin drives thromboinflammation and neuropathology in COVID-19
Nature · 2024-08-28 · 96 citations